Bit bio
VerifiedDeveloping a scalable technology platform capable of producing consistent batches of every human cell.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$412—618m (Dealroom.co estimates Nov 2021.)
Company register number 10466798
Cambridge England (HQ)
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 220 % | 1627 % | (56 %) | 457 % | (71 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | (1327 %) | (8104 %) | (2868 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | (1500 %) | (7824 %) | (2210 %) | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | $0.0 | round |
| investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor investor investor | $0.0 | round | |
| investor investor investor investor investor investor investor | $0.0 | round | |
N/A | - | ||
| Total Funding | 000k | ||
Related Content
Recent News about Bit bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.